NCT05502380View on ClinicalTrials.gov

Broad-spectrum Antibiotic Prophylaxis in Tumor and Infected Orthopedic Surgery

PHASE3RecruitingINTERVENTIONAL
Enrollment

1,100

Participants

Timeline

Start Date

September 15, 2022

Primary Completion Date

December 12, 2024

Study Completion Date

December 12, 2025

Conditions
Surgical Site InfectionMicrobial ColonizationAntibiotic Resistant Infection
Interventions
DRUG

Standard antibiotic prophylaxis

One to three intravenous doses of cefuroxime 1.5 g intravenously; or 3g if obesity; or vancomycin 1 g or clindamycin 600 mg; if allergy. Continuation of eventual current therapeutic antibiotc regimens for any infection

Trial Locations (1)

8008

RECRUITING

Balgrist University Hospital, Zurich

All Listed Sponsors
lead

Balgrist University Hospital

OTHER